For instance, Bai et al. recently showed that SD-36, a highly selective small-molecule degrader of STAT3, potently inhibits growth of a leukemia and lymphoma cell line(s) in vitro and induces durable tumor regression in vivo. This evidence concerns the gene STAT3 and leukemia.